AstraZeneca Foundation
Poorer countries hit with higher price tag for Oxford/AstraZeneca vaccine – POLITICO
Advancing data and artificial intelligence
Advancing data and artificial intelligence
AstraZeneca's vaccine has 76 percent efficacy—slightly lower than the interim results announced Monday
AstraZeneca plc | Access to Medicine Foundation
Keith Burns - Director of U.S. Tax Operations - AstraZeneca | LinkedIn
/cdn.vox-cdn.com/uploads/chorus_asset/file/22067800/GettyImages_1284434659.jpg "AstraZeneca-Oxford Covid-19 vaccine: Why it's different - Vox")
AstraZeneca-Oxford Covid-19 vaccine: Why it's different - Vox
IJERPH | Free Full-Text | Side-Effects following Oxford/AstraZeneca COVID-19 Vaccine in Tororo District, Eastern Uganda: A Cross-Sectional Study
AstraZeneca to acquire Neogene for $320 million
AstraZeneca weighs spinning out COVID-19 products into separate company: Bloomberg | Fierce Pharma
AstraZeneca nets $396M down payment from EU for 300M-plus COVID vaccines | Fierce Pharma
What science can do
Pakistan allows AstraZeneca shot for under 40s to help its expatriates | Reuters
Personified
Women's History Month: Celebrating Pioneers and Future Trailblazers
US finds COVID-19 Vaccine AstraZeneca safe and effective
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine | NEJM
